Sign in →

Test ID HIS Histone Autoantibodies, Serum

Useful For

Evaluating patients suspected of having drug-induced lupus

Method Name

Enzyme-Linked Immunosorbent Assay (ELISA)

Reporting Name

Histone Autoantibodies, S

Specimen Type

Serum

Container/Tube:

Preferred: Serum gel

Acceptable: Red top

Specimen Volume: 0.5 mL

Forms: If not ordering electronically, complete, print, and send a Neurology Test Request Form-General (T732) with the specimen (http://www.mayomedicallaboratories.com/it-mmfiles/neurology-request-form.pdf)

Specimen Minimum Volume

0.35 mL

Specimen Stability Information

Specimen Type Temperature Time
Serum Refrigerated (preferred) 21 days
  Frozen  21 days

Clinical Information

Histones are the most basic protein components of chromatin and their structures are highly conserved in different species. Five classes of histones called H1, H2, H2b, H3, and H4 have been described and are characterized by their molecular weights, ranging from 11 to 23 kilodalton (kD), and their content of the basic amino acids lysine and arginine.

 

Histone autoantibodies may react with any of the 5 classes of histones.(1,2) Autoantibodies to total histones are elicited by unknown mechanisms in patients treated with certain drugs, particularly procainamide, hydralazine, quinidine, alpha methyldopa, penicillamine, and isoniazid. Those patients may have signs and symptoms that resemble systemic lupus erythematosus (SLE). This disorder is identified as drug-induced lupus. Testing for autoantibodies to total histones is useful for evaluating patients suspected of having drug-induced lupus. Such patients will usually have a positive test for histone autoantibodies and a negative test for autoantibodies to double stranded DNA (dsDNA). Patients with SLE have positive tests for both types of autoantibodies.

Reference Values

<1.0 Units (negative)

1.0-1.5 Units (borderline)

>1.5 Units (positive)

Units are arbitrarily based on positive control serum.

Reference values apply to all ages.

Cautions

Positive tests for histone autoantibodies occur in some patients exposed to the above mentioned drugs who do not have signs or symptoms of lupus.

 

Testing for histone autoantibodies is not necessary to establish the diagnosis of systemic lupus erythematosus (SLE).

 

Test results are not useful for determining prognosis in patients with SLE or drug-induced lupus.

Day(s) Performed

Monday, Wednesday, Friday; 3:00 p.m.

Report Available

1 day

Performing Laboratory

Mayo Medical Laboratories in Rochester

Test Classification

This test has been cleared or approved by the U.S. Food and Drug Administration and is used per manufacturer's instructions. Performance characteristics were verified by Mayo Clinic in a manner consistent with CLIA requirements.

CPT Code Information

83516

NY State Approved

Yes